Missnöjd med din julklappsslips? Här är våra läsetips

Xvivo byter vd

Dag Andersson tar över vd-rollen efter grundaren Magnus Nilsson.

Follicum stärker teamet när klinik närmar sig

När bolagets nya läkemedelskandidat närmar sig klinik stärker bolaget upp sin expertis inom diabetes med ett vetenskapligt råd.

Studie: Barn har oftare antikroppar som korsreagerar med coronaviruset

Enligt en ny studie förekommer det ibland antikroppar hos personer som inte haft covid-19 som korsreagerar med det nya coronaviruset sars-cov-2.

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Elyptas cancertest har fått patent i USA

Testet kan tas från urin eller blod och möjliggör en säkrare och billigare metod för upptäckt av njurcancer.

New firm based on SLU research

Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.

New CEO to Medivir

The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Harmony prevents dementia

People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.

Anything is measurable

At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...

"Behöver vara enklare för patienter att hitta till lämpliga studier"

Jonas Venge och Ida Solvang båda Site Relationship and Excellence Partner på Pfizer kommenterar SwedenBios förslag om att möjliggöra för fler kliniska prövningar i Sverige.

Studie: Linagliptin gav inga hjärt- eller njurskador hos äldre med typ 2-diabetes

En nya studie visar att den aktiva substansen linagliptin (Trajenta) inte ger en högre risk för kardiovaskulära händelser.

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

Seminar program Biotech Forum

Here is the entire seminar program at Biotech Forum September 28-29th

Orexo vinner långdragen patenttvist

Amerikanska domstolen för överklagande slår fast att bolagets långa patent för Zubsolv är giltigt. Tidigare beslut som förklarade patentet ogiltigt rivs alltså upp.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Researchers goes to the bottom of the brain

Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.

Mathematician new dean at DTU

On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.